JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Role of CT scanning in the superior vena cava syndrome.

The value of computerized tomographic (CT) studies was compared to other imaging procedures in 18 consecutive patients with the superior vena cava syndrome (SVCS) during a 47-month period. Sixteen of these cases had proved malignancy. In addition to tumor masses, CT findings included effacement, compression, and displacement of the great vessels and the presence of thrombi and collateral blood flow. Significantly, tumor was demonstrated in the region of the superior vena cava in five patients in whom a definite mass could not be diagnosed by other means. CT scanning in a sixth case revealed that although mediastinal tumor was present it was not located in the immediate region of the occluded vessels. CT was corroborative and helpful in planning therapy in all but one of the remaining patients. CT scans appear to be of most value in cases of SVCS in whom other modalities cannot demonstrate tumor and, particularly, in excluding recurrent tumor in previously treated patients.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app